Detalles de la búsqueda
1.
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
Prostate
; 84(10): 954-958, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38641986
2.
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations.
Oncologist
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38885246
3.
Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort.
Prostate
; 83(6): 547-554, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632656
4.
Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer.
Prostate
; 83(12): 1186-1192, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211963
5.
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer.
Oncologist
; 28(6): 465-473, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37027449
6.
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images.
Mod Pathol
; 36(10): 100247, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307876
7.
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL.
Mol Imaging
; 2022: 7056983, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35283693
8.
Bipolar androgen therapy (BAT): A patient's guide.
Prostate
; 82(7): 753-762, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35357024
9.
Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies.
J Urol
; 206(3): 623-629, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003011
10.
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.
Prostate
; 80(5): 407-411, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31972048
11.
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on 18F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer.
J Urol
; 204(3): 496-502, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32250727
12.
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).
BMC Cancer
; 20(1): 492, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487038
13.
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
BMC Cancer
; 19(1): 572, 2019 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31196032
14.
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Prostate
; 78(5): 401-407, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29368341
15.
Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate.
Prostate
; 78(13): 992-1000, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29851094
16.
Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide.
Prostate
; 76(16): 1484-1490, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27404039
17.
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Nat Commun
; 15(1): 14, 2024 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38167882
18.
Role of bromodomain and extraterminal (BET) proteins in prostate cancer.
Expert Opin Investig Drugs
; 32(3): 213-228, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36857796
19.
Vascular Expression of Prostate-specific Membrane Antigen (PSMA) in MiTF Family Translocation Renal Cell Carcinoma and Related Neoplasms.
Appl Immunohistochem Mol Morphol
; 31(8): 544-549, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37471632
20.
Multi-timepoint imaging with PSMA-targeted [18F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging.
Ann Nucl Med
; 37(4): 246-254, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36857019